M
MediciNova, Inc. (MNOV)
NGM – Real Time Price. Currency in USD
1.38
-0.04 (-2.82%)
At close: Mar 27, 2026, 4:00 PM EDT
1.38
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:04 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
1.38
-0.04 (-2.82%)
At close: Mar 27, 2026, 4:00 PM EDT
1.38
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:04 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.16 | 6.05 | 10 | |
| Quick ratio | 8.16 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 1M | N/A | 410K | 410K |
| Gross Profit | -212K | 980K | -21K | 11K | -31K |
| Operating Income | -15M | -10M | -13M | -13M | -13M |
| Net Income | -14M | -9M | -11M | -12M | -12M |
| EBITDA | -14M | -10M | -13M | -13M | -13M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -39.89 | 1.0 |
| Next quarter | N/A | 32.79 | 5.5 |
| Current year | -59.32 | -25 | 1.0 |
| Next year | 320 | -38.33 | 5.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 23.05 | 8.13 | 33.33 | -18.2 | 6.8 |
| Y/Y | 999 | 0.44 | N/A | -4.39 | 3.5 |
| 3y average | 632.67 | 0.54 | 0.59 | 2.43 | 4.3 |
| 5y average | 559.4 | -2.06 | -0.8 | -3.31 | 3.3 |
| Weighted average score | 4.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $30.8M significantly exceed its total debt $211.5K, ensuring strong financial flexibility
Total current assets $31.0M exceed Total current liabilities $3.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.0M limits the company's ability to reinvest or pay down debt